Abstract
The spatiotemporal modeling of multiple diseases simultaneously is a recent extension that advances the space-time analysis to model multiple related diseases simultaneously. This approach strengthens inferences by borrowing information between related diseases. Numerous research contributions to spatiotemporal modeling approaches exhibit their strengths differently with increasing complexity. However, contributions that combine spatiotemporal approaches to modeling of multiple diseases simultaneously are not so common. We present a full Bayesian hierarchical spatio-temporal approach to the joint modeling of Human Immunodeficiency Virus and Tuberculosis incidences in Kenya. Using case notification data for the period 2012 - 2017, we estimated the model parameters and determined the joint spatial patterns and temporal variations. Our model included specific and shared spatial and temporal effects. The specific random effects allowed for departures from the shared patterns for the different diseases. The space-time interaction term characterized the underlying spatial patterns with every temporal fluctuation. We assumed the shared random effects to be the structured effects and the disease-specific random effects to be unstructured effects. We detected the spatial congruence in the distribution of Tuberculosis and Human Immunodeficiency Virus in approximately 29 counties around the western, central and southern regions of Kenya. The distribution of the shared relative risks had minimal difference with the Human Immunodeficiency Virus disease-specific relative risk whereas that of Tuberculosis presented many more counties as high-risk areas. The flexibility and informative outputs of Bayesian Hierarchical Models enabled us to identify the similarities and differences in the distribution of the relative risks associated with each disease. Estimating the Human Immunodeficiency Virus and Tuberculosis shared relative risks provide additional insights towards collaborative monitoring of the diseases and control efforts.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors would like to thank the African Union and the Pan African University Institute of Basic Sciences Technology and Innovation (PAUISTI) for funding the study through VO’s Ph.D. work
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The HIV and TB data used in this study are available from NASCOP (P.O. Box 19361-00202, Nairobi-Kenya; telephone: +254-775597297; info{at}nascop.or.ke; https://dwh.nascop.org/) and NLTP (P.O. Box 20781-00202, Nairobi-Kenya; telephone: +254-773977440; info{at}nltp.co.ke; http://pms.dltld.or.ke/). Interested researchers may contact Dr. Catherine Ngugi (head{at}nascop.or.ke) for the HIV data and Dr. Elizabeth Onyango (eonyango{at}nltp.co.ke) for the TB data. The county population estimates for the period 2012-2017 are available from the Keya National Bureau of Statistics (P.O. Box 30266-00100, Nairobi-Kenya; telephone: +254-20-317583; www.knbs.or.ke).
